Research Highlights: Among people with both obesity and an autoimmune disease, those taking GLP-1-based medications had fewer cardiac events, fewer emergency department visits and a decreased mortality
Gastrointestinal issues are the most common, with over half of patients reporting nausea during a clinical trial
That said, sales of berberine, a natural health supplement claimed to support weight management, continue to grow in the double digits (+21.6% in the year to Oct 6, 2024), he noted
Weight management GLP-1s have been seen as gamechangers from a clinical standpoint, helping people shed significant weight when paired with lifestyle modification
This is why I tell patients that treating obesity is treating cardiovascular disease